https://www.selleckchem.com/pr....oducts/LAQ824(NVP-LA
Tumor mutational burden (TM is an important independent biomarker for the response to immunotherapy in multiple cancers. However, the clinical implications of TMB in gastric cancer (GC) have not been fully elucidated. To explore the landscape of mutation profiles and determine the correlation between TMB and microRNA (miRNA) expression in GC. Genomic, transcriptomic, and clinical data from The Cancer Genome Atlas were used to obtain mutational profiles and investigate the statistical correlation between mutational burden an
Aimer
Commentaire
Partagez
